| [1] |
赵志刚，谢林，丁凡，等．利伐沙班预防关节置换术后下肢深静脉血栓的临床前瞻性对照研究[J]．中国矫形外科杂志，2016，24(07)：619-622.
|
| [2] |
熊涛，李秀山．利伐沙班预防骨科术后深静脉血栓及其对血液流变学的影响研究[J]．中华骨与关节外科杂志，2018，11(11)：846-848＋857.
|
| [3] |
Ishida K, Shibanuma N, Kodato K, et al. A prospective randomized comparative study to determine appropriate edoxaban administration period, to prevent deep vein thromboembolism in patients with total knee arthroplasty[J]. J Orthop Sci，2018，23(6)：1005-1010.
|
| [4] |
Nam D, Nunley RM, Johnson SR, et al. Thromboembolism prophylaxis in hip arthroplasty：routine and high risk patients[J]. J Arthroplasty，2015，30(12)：2299-303.
|
| [5] |
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141: 278-325.
|
| [6] |
中华医学会骨科学分会. 中国骨科大手术静脉血栓栓塞症预防指南[J]. 中华骨科杂志，2016, 36：65-69.
|
| [7] |
Chu JN, Maselli J, Auerbach AD, et al. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty[J]．Thrombosis research，2017，155：65-71.
|
| [8] |
Becattini C, Agnelli G. Aspirin for prevention and treatment of venous thromboembolism[J]. Blood Rev, 2014, 28 (1): 103-108.
|
| [9] |
Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4[J]. Blood, 2011, 118：1952-1961.
|
| [10] |
Undas A, Undas R, Musial J, et al. A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day)[J]. Blood Coagul Fibrinolysis, 2000，11：231-234.
|
| [11] |
Drescher FS, Sirovich BE, Lee A, et al. Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis[J]. J Hosp Med，2014，9(9)：579-85.
|
| [12] |
Tan TL, Foltz C, Huang R, et al. Potent anticoagulation does not reduce venous thromboembolism in high-risk patients[J]. J Bone Joint Surg Am，2019，101(7)：589-599.
|
| [13] |
Nadi S, Vreugdenburg TD, Atukorale Y, et al. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review[J]. 2019，15. doi: 10.1111/ans.15122. |
| [14] |
An VV, Phan K, Levy YD, et al. Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis[J]. J Arthroplasty, 31(11)：2608-2616.
|
| [15] |
Woon CYL, Shah RR, Pardi BM, et al. Aspirin alone is not enough to prevent deep venous thrombosis after total joint arthroplasty[J]．Orthopedics，2019，42(1)：48-55.
|
| [16] |
Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial[J]. Ann Intern Med, 2013，158(11)：800-806.
|
| [17] |
Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty[J]. N Engl J Med, 2018，378(8)：699-707.
|
| [18] |
Schaefer JK, Li Y, Gu X, et al. Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events[J]. JAMA Intern Med, 2019, 4. doi: 10.1001/jamainternmed.2018.7816. |
| [19] |
Hood BR, Cowen ME, Zheng HT, et al. Association of aspirin with prevention of venous thromboembolism in patients after total knee arthroplasty compared with other anticoagulants: a noninferiority analysis[J]. AMA Surg, 2018, 17. doi: 10.1001/jamasurg.2018.3858. |
| [20] |
Parvizi J, Huang R, Restrepo C, et al. Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis[J]. J Bone Joint Surg Am，2017，99(2)：91-98.
|